Skip to main content

Table 1 Studies included in the pooled DIAB-CORE sample (45–74 years)

From: Personal attributes that influence the adequate management of hypertension and dyslipidemia in patients with type 2 diabetes. Results from the DIAB-CORE Cooperation

Study Region Study period N (%) Age (years) Hypertension Dyslipidemia
     mean (SD) N (%) N (%)
SHIP a North-east 1997–2001 251 (19.5) 62.8 (7.5) 215 (85.7) 143 (57.0)
  Germany      
  (West Pomerania)      
DHS b West Germany 2003–2004 87 (6.8) 64.1 (8.0) 73 (83.9) -
  (Dortmund)      
CARLA c East Germany 2002–2006 174 (13.5) 63.5 (7.3) 155 (89.6) 84 (48.6)
  (Halle)      
HNR d West Germany (Bochum, Essen, Mülheim an der Ruhr) 2000–2003 350 (27.2) 63.0 (7.2) 263 (78.5) 174 (52.1)
KORA e South Germany 1999–2001 146 (11.3) 63.3 (6.7) 114 (78.6) 80 (55.9)
  (Augsburg region)      
GNHIES98 f Nationwide 1997–1999 279 (21.7) 62.7 (6.8) 228 (81.7) 155 (59.6)
Total   1997–2006 1287 63.1 (7.2) 1048 (82.5) 636 (54.8)
  1. aSHIP: Study of Health in Pomerania; bDHS: Dortmund Health Study; cCARLA: Cardiovascular Disease, Living and Ageing in Halle; d HNR: Heinz Nixdorf-Recall; eKORA (Survey S4): Cooperative Health Research in the Region of Augsburg; fGNHIES98: German National Health Interview and Examination Survey 1998.
  2. BP > = 140/90 mmHg or using anti-hypertensive medication.
  3. TC/HDL > = 5 or using lipid-lowering medication.